Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· April 3, 2026

Impact Analytics annonce un partenariat stratégique avec AllSaints

View original at globenewswire.com
Impact Analytics annonce un partenariat stratégique avec AllSaints LONDRES, 03 avr…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Brands like AllSaints are at a pivotal moment where speed, clarity and confidence in decision-making are essential

    60% confidence
  • One of AllSaints' four transformation pillars is to become a data-driven, AI-supported organization

    60% confidence
  • AllSaints team spends enormous time manually collecting and analyzing data, and this partnership will eliminate low-value repetitive tasks so merchandising managers can focus on understanding brand performance and making faster, better decisions

    60% confidence
  • With CortexEye, Monday reporting will be available by 8:00 AM detailed by department and team, enabling immediate business meetings and mid-day decision-making, compared to current process where data collection starts Sunday for Monday afternoon visibility

    60% confidence
  • Teams should be able to log in and immediately have a global view of what is happening across the brand worldwide and priorities to focus on, rather than having to search for this information

    60% confidence
  • This partnership aims to replace fragmented spreadsheets with a unified, AI-native platform and decision intelligence solution that strengthens merchandising team expertise, accelerates planning cycles and generates measurable impact on buying, pricing and inventory management decisions

    60% confidence
  • Impact Analytics is powered by over one million machine learning models and has been at the forefront of AI innovation for a decade, establishing new benchmarks in forecasting, planning and operational excellence

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com